Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
AIRelated Layoffs Fail to Deliver Expected Stock Boost Data Suggests Bernstein Initiates Coverage of Neurocrine Biosciences With Outperform Rating 221 Target Gold Correction May Be Approaching Its End as Sentiment Indicators Shift CoreWeave CRWV Identified Among Top Aschenbrenner Stock Picks US Payrolls Surge Past Forecasts But Report Reveals Underlying Economic Caution Incannex Healthcare IXHL Q1 2026 Earnings Deepening Losses as ClinicalStage Biotech Continues PreRevenue Development Toro Company Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Corbus Pharmaceuticals Q1 2026 Earnings SmallerThanExpected Loss Amid Pipeline Progress APOS Q1 2026 Earnings Apollo Global Management Reports Slight EPS Miss Revenue Not Disclosed UGRO Q3 2025 Earnings Significant EPS Miss Amidst Industry Challenges Horizon Quantum Holdings Surges 7 Key Levels to Watch One Liberty Properties OLP Holds Steady Near Support as Real Estate Sector Faces Headwinds Genie Energy GNE Holds Steady Near Support Amid Modest Decline Elevance Health Inc ELV Gains 125 as Stock Holds Above Key Support Pope Leo XIVs AI Encyclical Ignites Social Media Dune Memes Could Signal Regulatory Headwinds for Tech Sector JK Tyre Q4 Net Profit Surges 80 to Rs 178 Crore Announces Rs 4980 Crore Expansion Plan Global Markets Advance Amid IranUS Negotiation Hopes Oil Stays Elevated Above 100 Qualcomms Stock Surge Signals Growing Investor Confidence in AI Device Boom Gladstone Investment Corporation 4875 Notes due 2028 GAINZ Q1 2026 Earnings EPS Miss While Notes Trade Flat SID Q1 2026 Earnings Steelmaker Posts Wide EPS Miss Despite Positive Steel Demand Outlook Satellos Bioscience Q1 2026 Earnings Narrower Loss Reported Stock Slips on Lack of Revenue Progress Southwest Airlines LUV Q1 2026 Earnings EPS Misses Estimates Amid Cost Headwinds Brookfield Renewable Partners Q1 2026 Earnings Widely Missed EPS Estimates as Operating Challenges Persist KALV Q1 2026 Earnings Narrower Loss Beats Expectations Clinical Pipeline Progress Underway